For citations:
Popov S.S., Anufrieva E.I., Krylskiy E.D., Shulgin K.K., Verevkin A.N., Pashkov A.N., Bolotskikh V.I., Volynkina A.P. The effect of combined melatonin therapy on indicators of oxidative status in chronic kidney disease developing in type 2 diabetes mellitus. Clinical Medicine (Russian Journal). 2021;99(2):121-127. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-2-121-127
Email this article 